References
- ZouboulisCCEadyAPhilpottMWhat is the pathogenesis of acne?Exp Dermatol200514214315215679586
- KurokawaIDanbyFWJuQNew developments in our understanding of acne pathogenesis and treatmentExp Dermatol2009181082183219555434
- ZouboulisCCJourdanEPicardoMAcne is an inflammatory disease and alterations of sebum composition initiate acne lesionsJ Eur Acad Dermatol Venereol201428552753224134468
- KoreckAPivarcsiADobozyAKemenyLThe role of innate immunity in the pathogenesis of acneDermatology200320629610512592074
- LeydenJAdapalene in clinical practiceCutis2001684 Suppl7911845950
- BershadSPoulinYPBersonDSTopical retinoids in the treatment of acne vulgarisCutis1999642 Suppl820 quiz 21–2310472493
- ThielitzASidouFGollnickHControl of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%J Eur Acad Dermatol Venereol200721674775317567301
- BabaeinejadSHFouladiRFThe efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trialJ Drugs Dermatol20131291033103824002152
- BettoliVBorghiAZauliSMaintenance therapy for acne vulgaris: efficacy of a 1 2-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literatureDermatology201322729710224029411
- ChibaKYoshizawaKMakinoIKawakamiKOnoueMComedogenicity of squalene monohydroperoxide in the skin after topical applicationJ Toxicol Sci2000252778310845185
- FengXZhangLZhuHComparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761)Planta Med200975879279619288403
- LiuJHChenMMHuangJWTherapeutic effects and mechanisms of action of mannitol during H2O2-induced oxidative stress in human retinal pigment epithelium cellsJ Ocul Pharmacol Ther201026324925720565311
- GoldieMDolanSBilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in ratsBehav Pharmacol201324429830623838965
- CavoneLCalosiLCinciLMoroniFChiarugiATopical mannitol reduces inflammatory edema in a rat model of arthritisPharmacology2012891–2182122236612
- KaulRIn vitro Kinetik der anti-Staphylococcus Aktivität von Bakuciol. [Kinetics of the anti-staphylococcal activity of bakuchiol in vitro (author’s transl)]Arzneimittelforschung1976264486489 German989003
- KatsuraHTsukiyamaRISuzukiAKobayashiMIn vitro antimicrobial activities of bakuchiol against oral microorganismsAntimicrob Agents Chemother200145113009301311600349
- FerrándizMLGilBSanzMJEffect of bakuchiol on leukocyte functions and some inflammatory responses in miceJ Pharm Pharmacol19964899759808910867
- PaeHOChoHOhGSBakuchiol from Psoralea corylifolia inhibits the expression of inducible nitric oxide synthase gene via the inactivation of nuclear transcription factor-kappaB in RAW 264.7 macrophagesInt Immunopharmacol200119–101849185511562076
- ChaudhuriRKBojanowskiKBakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effectsInt J Cosmet Sci201436322123024471735
- MesserschmidtASchultheisKOchsendorfFTopische Benhandlung von Infektionen, Tumoren und Hyperkeratosen. [Topical treatment of infections, tumors and hyperkeratotic disorders]Hautarzt2014653207217 German24500043
- PoiraudCQuereuxGKnolACAllixRKhammariADrenoBZinc gluconate is an agonist of peroxisome proliferator-activated receptor-alpha in the epidermisExp Dermatol201221534735122509831
- LodenMRole of topical emollients and moisturizers in the treatment of dry skin barrier disordersAm J Clin Dermatol200341177178814572299
- IshidaTMizushinaYYagiSInhibitory effects of glycyrrhetinic acid on DNA polymerase and inflammatory activitiesEvid Based Complement Alternat Med2012201265051421785649
- MotleyRJFinlayAYPractical use of a disability index in the routine management of acneClin Exp Dermatol1992171131424249
- ZouboulisCCAcne as a chronic systemic diseaseClin Dermatol201432338939624767186
- DosikJSHomerKArsonnaudSCumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%Cutis200575423824315916222
- DosikJSHomerKArsonnaudSCumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%Cutis200575528929315984630